Literature DB >> 22612859

Spectrum of autoantibodies in Tunisian psychiatric inpatients.

Oussama Sidhom1, Lilia Laadhar, Mondher Zitouni, Nissaf Ben Alaya, Rym Rafrafi, Marayam Kallel-Sellami, Houria Lahmar, Zouhair El Hechmi, Sondes Makni.   

Abstract

One hundred and three psychiatric inpatients (74 men) were assessed for a wide spectrum of autoantibodies including antinuclear, antismooth muscle, antimitochondrial, antiDNA, anti-phospholipid, anti-cardiolipin IgG and IgM, antikeratin, rheumatoid factor, antithyroperoxydase, antigliadin IgA and IgG, antitransgutaminase, and antiendomysium antibodies. Four groups of patients were considered separately, including 47 with schizophrenia, 23 with schizoaffective disorder, 16 with bipolar disorder and 17 patients with other different psychiatric diagnosis. Forty one healthy, age- and sex-matched blood donors were used as a control group. There were no significant difference in the prevalence of the different autoantibodies between patients (N = 103) and controls except for antigliadin IgG (30.1 vs 9.8 respectively, p = 0.01). Presence of autoantibodies was influenced by age but not by sex or treatment. As for diagnosis categories, patients with bipolar disorder presented significantly more autoantibodies than the three other categories and controls. These results point out a possible autoimmune activation in at least a subgroup of psychiatric patients especially amongst those suffering from bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612859     DOI: 10.3109/08820139.2012.685537

Source DB:  PubMed          Journal:  Immunol Invest        ISSN: 0882-0139            Impact factor:   3.657


  13 in total

1.  Improvement in psychotic symptoms after a gluten-free diet in a boy with complex autoimmune illness.

Authors:  William W Eaton; Lian-Yu Chen; F Curtis Dohan; Deanna L Kelly; Nicola Cascella
Journal:  Am J Psychiatry       Date:  2015-03-01       Impact factor: 18.112

2.  Randomized controlled trial of a gluten-free diet in patients with schizophrenia positive for antigliadin antibodies (AGA IgG): a pilot feasibility study

Authors:  Deanna L. Kelly; Haley K. Demyanovich; Katrina M. Rodriguez; Daniela Ciháková; Monica V. Talor; Robert P. McMahon; Charles M. Richardson; Gopal Vyas; Heather A. Adams; Sharon M. August; Alessio Fasano; Nicola G. Cascella; Stephanie M. Feldman; Fang Liu; MacKenzie A. Sayer; Megan M. Powell; Heidi J. Wehring; Robert W. Buchanan; James M. Gold; William T. Carpenter; William W. Eaton
Journal:  J Psychiatry Neurosci       Date:  2019-07-01       Impact factor: 6.186

3.  Seroreactive marker for inflammatory bowel disease and associations with antibodies to dietary proteins in bipolar disorder.

Authors:  Emily G Severance; Kristin L Gressitt; Shuojia Yang; Cassie R Stallings; Andrea E Origoni; Crystal Vaughan; Sunil Khushalani; Armin Alaedini; Faith B Dickerson; Robert H Yolken
Journal:  Bipolar Disord       Date:  2013-12-06       Impact factor: 6.744

Review 4.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

5.  IgG dynamics of dietary antigens point to cerebrospinal fluid barrier or flow dysfunction in first-episode schizophrenia.

Authors:  Emily G Severance; Kristin L Gressitt; Armin Alaedini; Cathrin Rohleder; Frank Enning; J Malte Bumb; Juliane K Müller; Emanuel Schwarz; Robert H Yolken; F Markus Leweke
Journal:  Brain Behav Immun       Date:  2014-09-20       Impact factor: 7.217

6.  Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data.

Authors:  Daniel S Tylee; Jiayin Sun; Jonathan L Hess; Muhammad A Tahir; Esha Sharma; Rainer Malik; Bradford B Worrall; Andrew J Levine; Jeremy J Martinson; Sergey Nejentsev; Doug Speed; Annegret Fischer; Eric Mick; Brian R Walker; Andrew Crawford; Struan F A Grant; Constantin Polychronakos; Jonathan P Bradfield; Patrick M A Sleiman; Hakon Hakonarson; Eva Ellinghaus; James T Elder; Lam C Tsoi; Richard C Trembath; Jonathan N Barker; Andre Franke; Abbas Dehghan; Stephen V Faraone; Stephen J Glatt
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-10-16       Impact factor: 3.568

7.  Gluten Psychosis: Confirmation of a New Clinical Entity.

Authors:  Elena Lionetti; Salvatore Leonardi; Chiara Franzonello; Margherita Mancardi; Martino Ruggieri; Carlo Catassi
Journal:  Nutrients       Date:  2015-07-08       Impact factor: 5.717

8.  Increased M1/decreased M2 signature and signs of Th1/Th2 shift in chronic patients with bipolar disorder, but not in those with schizophrenia.

Authors:  P Brambilla; M Bellani; M Isola; A Bergami; V Marinelli; N Dusi; G Rambaldelli; M Tansella; A Maria Finardi; G Martino; C Perlini; R Furlan
Journal:  Transl Psychiatry       Date:  2014-07-01       Impact factor: 6.222

Review 9.  Celiac and non-celiac gluten sensitivity: a review on the association with schizophrenia and mood disorders.

Authors:  Brunetta Porcelli; Valeria Verdino; Letizia Bossini; Lucia Terzuoli; Andrea Fagiolini
Journal:  Auto Immun Highlights       Date:  2014-10-16

Review 10.  The epidemiologic evidence linking autoimmune diseases and psychosis.

Authors:  Michael E Benros; William W Eaton; Preben B Mortensen
Journal:  Biol Psychiatry       Date:  2013-10-03       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.